Heidelberg University Hospital orders IBA ProteusONE proton therapy system

Heidelberg University Hospital has signed a contract with IBA to install a ProteusONE compact proton therapy solution on its campus in Heidelberg, Germany. The system, valued between EUR 35-45 million, is expected to start treating patients in the second half of 2030.

“We are proud to sign a contract with such a renowned and experienced institution.”biowin.org

• 1 source
• biowin.orgHeidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution - BioWinAug 20, 2025

Summarized from public sources; check the original articles before acting on it.